Patents Assigned to Canvir, Inc.
  • Advanced cervical cell screening methods
    Patent number: 7838215
    Abstract: Advanced cervical cancer screening methods that provide a molecular based process of detecting HPV-integration. The disclosed methods allow for a streamlined approach of conducting a Pap test and immunohistochemical test on the same slide. The disclosed methods provides an inexpensive, highly sensitive, specific, and detailed test that is easy to evaluate and follow-up.
    Type: Grant
    Filed: September 16, 2008
    Date of Patent: November 23, 2010
    Assignee: Canvir, Inc.
    Inventors: Peter Gombrich, Mitchell Golbus